东诚药业(002675.SZ)：氟[18F]思睿肽注射液III期临床试验完成全部受试者入组

智通财经2025-06-13

智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司控股子公司烟台蓝纳成生物技术股份有限公司(“蓝纳成”)组织开展的氟[18F]思睿肽注射液III期临床试验，目前已完成全部488例受试者入组。氟[18F]思睿肽注射液是一种靶向PSMA的放射性体内诊断药物，适用于下述前列腺癌患者前列腺特异性膜抗原(PSMA)阳性病灶的正电子发射断层扫描(PET)成像：(1)拟接受初始根治性治疗，怀疑...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2543506628?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-13 16:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2543506628","market":"us","top_or_hot":-1,"title":"东诚药业(002675.SZ)：氟[18F]思睿肽注射液III期临床试验完成全部受试者入组","media":"智通财经","content":"<div>\n<p>智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司控股子公司烟台蓝纳成生物技术股份有限公司(“蓝纳成”)组织开展的氟[18F]思睿肽注射液III期临床试验，目前已完成全部488例受试者入组。氟[18F]思睿肽注射液是一种靶向PSMA的放射性体内诊断药物，适用于下述前列腺癌患者前列腺特异性膜抗原(PSMA)阳性病灶的正电子发射断层扫描(PET)成像：(1)拟接受初始根治性治疗，怀疑...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1304950.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>东诚药业(002675.SZ)：氟[18F]思睿肽注射液III期临床试验完成全部受试者入组</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n东诚药业(002675.SZ)：氟[18F]思睿肽注射液III期临床试验完成全部受试者入组\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-13 16:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1304950.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司控股子公司烟台蓝纳成生物技术股份有限公司(“蓝纳成”)组织开展的氟[18F]思睿肽注射液III期临床试验，目前已完成全部488例受试者入组。氟[18F]思睿肽注射液是一种靶向PSMA的放射性体内诊断药物，适用于下述前列腺癌患者前列腺特异性膜抗原(PSMA)阳性病灶的正电子发射断层扫描(PET)成像：(1)拟接受初始根治性治疗，怀疑...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1304950.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1304950.html","article_id":"2543506628","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2543506628","pubTimestamp":1749803543,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，东诚药业 发布公告，近日，公司控股子公司烟台蓝纳成生物技术股份有限公司组织开展的氟[18F]思睿肽注射液III期临床试验，目前已完成全部488例受试者入组。氟[18F]思睿肽注射液是一种靶向PSMA的放射性体内诊断药物，适用于下述前列腺癌患者前列腺特异性膜抗原阳性病灶的正电子发射断层扫描成像：拟接受初始根治性治疗，怀疑存在转移灶的前列腺癌患者;血清前列腺特异性抗原水平升高，怀疑生化复发的前列腺癌患者。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0239":"医药制造","III":"信息服务","03347":"泰格医药","BK1583":"高瓴概念","BK1141":"生命科学工具和服务","BK4134":"信息科技咨询与其它服务","002675":"东诚药业","BK1576":"医药外包概念"},"translate_title":"Dongcheng Pharmaceutical (002675. SZ): The phase III clinical trial of fluoride [18F] seruitide injection completed the enrollment of all subjects","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"III":1,"03347":1,"002675":1},"content_text":"智通财经APP讯，东诚药业(002675.SZ)发布公告，近日，公司控股子公司烟台蓝纳成生物技术股份有限公司(“蓝纳成”)组织开展的氟[18F]思睿肽注射液III期临床试验，目前已完成全部488例受试者入组。氟[18F]思睿肽注射液是一种靶向PSMA的放射性体内诊断药物，适用于下述前列腺癌患者前列腺特异性膜抗原(PSMA)阳性病灶的正电子发射断层扫描(PET)成像：(1)拟接受初始根治性治疗，怀疑存在转移灶的前列腺癌患者;(2)血清前列腺特异性抗原(PSA)水平升高，怀疑生化复发的前列腺癌患者。氟[18F]思睿肽与PSMA蛋白具有较高的特异性和亲和力，可在PSMA高表达的肿瘤中高度浓聚，从而可以将氟[18F]带至前列腺癌患者PSMA表达阳性部位，采用正电子发射断层扫描(PET)成像技术实现诊断目的。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2543506628","isCrawlerRequest":true}